Peter Houston: Could Pharma Use Tumblr and Survive?

In this 3-minute audio snippet, Peter Houston, founder of Flipping Pages Media Ltd, discusses the pros and cons of Tumblr and whether it is possible for pharma marketers to get involved with Tumblr. Is it too Early?

Roland Andersson & Thomas Krohn: Transcelerate BioPharma Initiative

In this 4-minute audio snippet, Roland Andersson, Director for Accenture's Life Sciences R&D practice, and Thomas Krohn, Director, Clinical Open Innovation, Eli Lilly, discuss the Transcelerate Biopharma initiative, the goals of which are to increase compliance and the productivity of clinical trials.

Jerry Matczak: Open Innovation Engages Patients in Pharma R&D

In this 4-minute audio snippet, Jerry Matczak, Community Manager for the Lilly Clinical Open Innovation Team, explains how the Internet, transparency, sharing innovation, and engaging patients in online communities can change how pharmaceutical companies do research.

Ambre Morley: Vetting Celebrity Spokespersons to Ensure Return on Investment

In this 2-minute audio snippet, Ambre Morley, Associate Director, Product Communications, Novo Nordisk, talks about vetting Paula Deen as a paid celebrity spokesperson for the Novo Victoza diabetes drug franchise and the importance of measuring celebrity return on investment (ROI).

Pharmaguy™’s Twitter Stream – Q2 2010

Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News

Preeti Pinto: How Marketers & Regulatory People Can Just Get Along

In this 3-minute audio snippet, Preeti Pinto, a regulatory consultant and former Executive Director & Head of Promotional Regulatory Affairs at AstraZeneca, talks about how regulatory-savvy pharma marketers are in a better position to challenge their regulatory colleagues when they say 'No.'

Lea Katsanis: Benefits & Risks of Rx Brand Personality

In this 2.5-minute audio snippet, Lea Katsanis, PhD, Marketing Professor at Concordia University's John Molson School of Business, talks about Rx brand personalities as perceived by consumers and how pharmaceutical marketers can use or abuse how consumers perceive their brands' human characteristics.

Pharmaguy™

Pharmaguy™ is a Pharma Marketing 'Constructive' Critic, Blogger & Chief Pundit at Pharmaguy.com

5-Minute Audio Podcasts

Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News

Patricia Alves and Jaclyn Fonteyne: TweetChat Return on Investment

In this 2.5-minute audio snippet, Patricia Alves and Jaclyn Fonteyne, members of the Boehringer Ingelheim Social Media Team, talk about the working with legal-regulatory to plan TweetChats and what they consider to be the measures of success -- aka, return on investment -- for pharma TweetChats.
- Advertisement -